share_log

博腾股份(300363.SZ):拟变更部分募集资金用途

Porton pharma solutions (300363.SZ): plans to change part of the use of raised funds.

Gelonghui Finance ·  Dec 10, 2024 16:47

On December 10, Gelonghui reported that Porton Pharma Solutions (300363.SZ) announced that due to significant changes in the main factors affecting the feasibility of the originally planned project, and considering various factors such as the company's actual situation and development planning, in order to further improve the efficiency of the use of raised funds, the company intends to use the unused balance of the originally raised funds for the project "New Drug Service Outsourcing Base R&D Center Construction Project (Phase II)" (including the net amount of accumulated interest income, with a balance of 198.0161 million yuan as of November 30, 2024, the actual amount will be based on the amount in the dedicated account on the day of fund transfer) entirely for permanently supplementing working capital.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment